Biomaterials Medal, the UK Society for Biomaterials President's Prize and the Acta Metallurgica Hollman Award. Professor Bonfield was also elected as a Fellow of the Royal Society, Royal Academy of Engineering and the Academy of Medical Sciences.
The papers in this special double issue demonstrate the significant advances made in medical materials research but also identify the numerous challenges ahead. They are presented in two parts: the first is dedicated to particles and drug delivery and the second to tissue engineering. In this first part, the scene is set by Hench & Thompson's (2010) overview paper, which explores the 'twenty-first century challenges for biomaterials'. Subsequently, the papers encompass the preparation, characterization and use of particles of advanced medical materials covering all size scales. Enayati et al. (2010) demonstrate how flow of material under an electric field can be used to mass produce drug delivery particles with control over both size and shape. The paper by Doshi & Mitragotri (2010) illustrates the crucial importance of particle shape in biological processes and the significant impact that control of shape can have on drug delivery applications. In their paper, Yang et al. (2010) elucidate some of the immense benefits of using nanoparticles in medicine; however, they also point out potential dangers, and how understanding and controlling these in healthcare and consumer applications represent a major challenge in the development of medical materials for the next few decades. The selection of polymer particles for drug encapsulation is a colossal task if based only on experimentation, and in their paper Ahmad et al. (2010) show how solutions of this task can be accelerated by using computer model simulations. The contribution of Abalde-Cela et al. (2010) illustrates how important it is to develop analytical tools to detect minute concentrations of molecular species when using particles in biomedical applications. They show how surfaceenhanced Raman scattering spectral analysis has advanced in leaps and bounds over the last few years in order to facilitate this task and the authors also identify the challenges faced in key areas such as multiplexing and high-throughput screening. The paper by Chang et al. (2010) uncovers a unique electrically driven, commercially scalable processing method to prepare fine polymer shelled hollow capsules, controlling both the shell thickness and capsule diameter and they go on to indicate how the shape of the capsules can also be changed. The paper by Ye et al. (2010) complements this area of research very well by reporting their research on the use of microfluidic processing to generate polymer particles and capsules, and illustrate further how the polymer material can be converted to ceramic. In their papers, Ankola et al. (2010) and Schiffter et al. (2010) illustrate two invaluable examples of nanoscale drug delivery. The first paper shows how a high-molecular-weight drug can be delivered more efficiently using novel carboxylated multi-block co-polymers. The second demonstrates how insulin can be very effectively delivered using fine particulate suspensions, spray freeze drying and needle-free ballistic technology.
We are extremely grateful to all the authors for contributing these papers, which describe some of their current cuttingedge research. In addition to the scientific contribution, these works demonstrate how communities worldwide can be helped by research to 'Scale the heights' in order to speedily tackle the challenges faced in medical materials, from concept to patient, which is a key feature of Professor Bonfield's work.
